Science-Based, Passion-Driven

We are advancing an innovative, high-value product portfolio for patients globally.

Learn More
doctor_and_patient

Passion with Purpose

We work to benefit patients wherever they live by uniting worldwide talent and resources with our vision.

Learn More
people_walking

Our Commitment to Patients

We offer resources to help patients and their loved ones navigate some of the complex challenges that follow the words, “You have cancer.”

Learn More
elder_women

BeiGene News

March 4, 2025

TEVIMBRA Approved in U.S. for First-line Treatment of Advanced Esophageal Squamous Cell Carcinoma in Combination with Chemotherapy

Read more

February 27, 2025

BeiGene Announces Fourth Quarter and Full Year 2024 Financial Results and Business Updates

Read more

February 25, 2025

BeiGene to Present at Upcoming Investor Conferences

Read more

February 13, 2025

BeiGene to Announce Fourth Quarter and Full Year 2024 Financial Results on February 27

Read more

January 6, 2025

BeiGene Announces Appointment of Giancarlo Benelli as Head of Europe

Read more

December 27, 2024

TEVIMBRA Approved in U.S. for First-line Treatment of Gastric and Gastroesophageal Junction Cancers in Combination with Chemotherapy

Read more